{"disease":{"id":"palmoplantar-pustulosis-ppp","name":"palmoplantar pustulosis ppp"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06790940","title":"Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Information","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":310,"lead_sponsor_name":"Shanghai Yueyang Integrated Medicine Hospital","has_results":false},{"nct_id":"NCT04015518","title":"A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT07530367","title":"A Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Tofacitinib Combined With Imatinib in Patients With Moderate-to-Severe Palmoplantar Pustulosis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":135,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04451720","title":"Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT07270003","title":"A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Xijing Hospital","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}